Treatment of hepatitis C with daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy in patients who are treatment naive or have previously failed an interferon based therapy.

被引：0
|
作者：
Lawitz, EJ [1 ]
Kadakia, SC [1 ]
Cantu, N [1 ]
Nader, P [1 ]
Cox, J [1 ]
Ganeshappa, KP [1 ]
Reddy, G [1 ]
Nguyen, TT [1 ]
Diamond, K [1 ]
Lindner, M [1 ]
Ostower, V [1 ]
Vemura, R [1 ]
机构：
[1] Brooke Army Med Ctr, San Antonio, TX USA
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)81746-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
6625
引用
收藏
页码：A1462 / A1462
页数：1
相关论文
共 50 条
  • [41] High induction doses of interferon plus ribavirin followed by daily dosing with combination therapy in patients with chronic hepatitis C: An interim report.
    Conjeevaram, HS
    Madrigal, A
    Al-Saden, P
    Baker, AL
    HEPATOLOGY, 1999, 30 (04) : 634A - 634A
  • [42] Treatment of naive chronic hepatitis C patients with induction therapy of interferon plus ribavirin shows similar results to those found with pegylated interferons plus ribavirin therapy.
    Silva, LC
    Medeiros, JE
    Pinho, JR
    Carrilho, FJ
    HEPATOLOGY, 2001, 34 (04) : 587A - 587A
  • [43] Lamivudine monotherapy and interferon plus lamivudine combination therapy in anti-HBe positive patients with chronic hepatitis B who have failed previously interferon treatment
    Akarca, US
    Ersoz, G
    Karasu, Z
    Gunsar, F
    Kilincsoy, N
    Batur, Y
    JOURNAL OF HEPATOLOGY, 2001, 34 : 167 - 167
  • [44] Combination therapy with ribavirin and alpha interferon for the treatment of chronic hepatitis C refractory to interferon
    Cozzolongo, R
    Cuppone, R
    Giannuzzi, V
    Amati, L
    Caradonna, L
    Tamborrino, V
    Jirillo, E
    Manghisi, OG
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (01) : 129 - 135
  • [45] A Comparison of Interferon alpha-2a Plus Ribavirin Combination Therapy with Peginterferon alpha-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
    Demiraslan, Hayati
    Aygen, Bilgehan
    Yildiz, Orhan
    Soyuer, Isin
    Gokahmetoglu, Selma
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2008, 13 (01): : 12 - 22
  • [46] Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection
    Beckebaum, S
    Cicinnati, VR
    Karliova, M
    Dirsch, O
    Erim, Y
    Frilling, A
    Malago, M
    Broelsch, CE
    Treichel, U
    Gerken, G
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (06) : 2080 - 2081
  • [47] Improved clinical and virologic response is achieved with daily interferon α-2b plus ribavirin in the therapy of treatment-naive hepatitis C patients, and terminates viremia in some hepatitis C retreatment patients.
    King, JW
    Markanday, A
    Khan, AA
    Favrot, DR
    Vanderburg, AC
    Stevens, L
    Alam, M
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 319 - 319
  • [48] High dose induction therapy with consensus interferon and ribavirin for treatment-naive patients with hepatitis C.
    Kaiser, S
    Hass, H
    Gregor, M
    HEPATOLOGY, 2002, 36 (04) : 362A - 362A
  • [49] Efficacy of Conventional Interferon alpha-2 b plus Ribavirin combination in the treatment of chronic Hepatitis C naive patients
    Farooqi, Javed Iqbal
    Farooqi, Rukhsana Javed
    RAWAL MEDICAL JOURNAL, 2005, 30 (01):
  • [50] COST EFFECTIVENESS OF PEGYLATED-INTERFERON ALPHA 2B+RIBAVIRIN FOR CHRONIC HEPATIITIS C (CHC) IN PATIENTS WHO HAVE PREVIOUSLY FAILED TREATMENT WITH INTERFERON- BASED THERAPY IN AUSTRALIA
    Norris, S.
    Campbell, S.
    Radalj, L.
    Elliott, L.
    Dunlop, S. L.
    VALUE IN HEALTH, 2009, 12 (07) : A424 - A424
12345